C
Christoph Härtel
Researcher at University of Lübeck
Publications - 176
Citations - 4076
Christoph Härtel is an academic researcher from University of Lübeck. The author has contributed to research in topics: Medicine & Low birth weight. The author has an hindex of 35, co-authored 132 publications receiving 3311 citations. Previous affiliations of Christoph Härtel include Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
Wolfgang Göpel,Angela Kribs,Andreas Ziegler,Reinhard Laux,Thomas Hoehn,Christian Wieg,Jens Siegel,Stefan Avenarius,Axel von der Wense,Matthias Vochem,Peter Groneck,Ursula Weller,Jens Möller,Christoph Härtel,Sebastian Haller,Bernhard Roth,Egbert Herting +16 more
TL;DR: The application of surfactant via a thin catheter to spontaneously breathing preterm infants receiving continuous positive airway pressure reduces the need for mechanical ventilation.
Journal ArticleDOI
Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes.
TL;DR: Data suggest that vitamin C selectively influences intracytoplasmic cytokine production and therefore, further studies are needed to elucidate the underlying mechanisms of immunomodulation, i.e. regulation of NF kappa B activation which is mandatory for the induction of pro-inflammatory cytokines.
Journal ArticleDOI
Immature anti-inflammatory response in neonates.
TL;DR: It is concluded that neonates display an immature compensatory anti‐inflammatory response syndrome (CARS) which may predispose preterm infants to harmful effects of proinflammatory cytokines resulting in severe organ sequelae during infection.
Journal ArticleDOI
Cytokine responses correlate differentially with age in infancy and early childhood
Christoph Härtel,N. Adam,Tobias Strunk,P. Temming,Michael Müller-Steinhardt,Christian Schultz +5 more
TL;DR: These findings are valuable for further assessment of normal variations and maturation processes in immune cell responses and for the clinical–therapeutic monitoring of immunological status in various childhood diseases.
Journal ArticleDOI
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
Martin Nitschke,Friedhelm Sayk,Christoph Härtel,Rahel T. Roseland,Susanne Hauswaldt,Jürgen Steinhoff,Klaus Fellermann,Inge Derad,Peter Wellhöner,Jürgen Büning,Bettina Tiemer,Alexander Katalinic,Jan Rupp,Hendrik Lehnert,Werner Solbach,Johannes K.-M. Knobloch +15 more
TL;DR: Treatment with azithromycin was associated with a lower frequency of long-term STEC O104:H4 carriage, and no recurrence of STEC was observed in patients with HUS and outpatients without manifestation of HUS.